Drugs Made In America Acquisition Corp. (DMAAU) Interest & Investment Income (2025)
Drugs Made In America Acquisition's (DMAAU) quarterly Interest & Investment Income came in at $2.3 million in Q4 2025, down 5.96% on a QoQ basis from $2.4 million in Q3 2025.
Drugs Made In America Acquisition Corp. (DMAAU) Interest & Investment Income (2025) Analysis & Trends
Drugs Made In America Acquisition (DMAAU) has 1 years of Interest & Investment Income data on file, last reported at $2.3 million in Q4 2025.
- Quarterly Interest & Investment Income changed N/A year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.8 million (changed N/A YoY) and the FY2025 annual result came in at $8.8 million, changed N/A from the prior year.
- Interest & Investment Income slipped to $2.3 million in Q4 2025, from $2.4 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.4 million in Q3 2025 to a low of $1.6 million in Q1 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.30 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.42 Mn |
| Mar 31, 2025 | 1.59 Mn |